Shruthi Naik

Shruthi Naik has a diverse work experience spanning over several years. Their most recent position is as an Associate Consultant at Mayo Clinic Rochester, where they started in July 2021. Prior to that, they worked at Vyriad as a VP Comparative Oncology from February 2016 onwards. From January 2013 to February 2016, they held the position of Chief Scientific Officer at Omnis Pharmaceuticals.

Shruthi Naik has also worked at Mayo Clinic as a Postdoctoral fellow in the Department of Molecular Medicine, focusing on the development and clinical translation of novel oncolytic therapies for Cancer treatment. Shruthi held this position from May 2011 to January 2015.

Before joining Mayo Clinic, Shruthi Naik worked at the University of Texas at Dallas as an Undergraduate Researcher from August 2003 to December 2005. Shruthi also served as a Student Union and Activities Board Organizer from July 2004 to May 2005.

In addition, Shruthi Naik briefly worked as a Research Fellow at Mayo Clinic from May 2005 to August 2005.

Overall, Shruthi Naik has gained extensive experience and expertise in the field of oncology, specifically in the development of novel therapies and scientific research.

Shruthi Naik obtained a Bachelor of Science (B.S.) degree in Molecular Biology, Economics & Finance from The University of Texas at Dallas, where they studied from 2002 to 2006. Shruthi then pursued their Doctor of Philosophy (Ph.D.) degree in Biomedical Sciences, specializing in Biochemistry & Molecular Biology, Oncology, from the Mayo Clinic Graduate School of Biomedical Sciences, where they studied between the years 2006 and 2010.